Functional tissue regeneration is required for the restoration of normal organ homeostasis after severe injury. Some organs, such as the intestine, harbour active stem cells throughout homeostasis and regeneration 1 ; more quiescent organs, such as the lung, often contain facultative progenitor cells that are recruited after injury to participate in regeneration 2,3 . Here we show that a Wntresponsive alveolar epithelial progenitor (AEP) lineage within the alveolar type 2 cell population acts as a major facultative progenitor cell in the distal lung. AEPs are a stable lineage during alveolar homeostasis but expand rapidly to regenerate a large proportion of the alveolar epithelium after acute lung injury. AEPs exhibit a distinct transcriptome, epigenome and functional phenotype and respond specifically to Wnt and Fgf signalling. In contrast to other proposed lung progenitor cells, human AEPs can be directly isolated by expression of the conserved cell surface marker TM4SF1, and act as functional human alveolar epithelial progenitor cells in 3D organoids. Our results identify the AEP lineage as an evolutionarily conserved alveolar progenitor that represents a new target for human lung regeneration strategies.
alveolar destruction (Fig. 1i ). We used this spatially specific response to analyse the contribution of AEPs to lung regeneration.
Recent studies have shown that Sox2-derived Krt5 + epithelial cells migrate to damaged distal lung regions to re-create an epithelial barrier [6] [7] [8] [9] [10] . We observe Krt5 + epithelium specifically in zone 4 after influenza infection (Extended Data Fig. 4a -d, f), but lineage tracing demonstrates that no Krt5 + cells are derived from AEPs (Extended Data Fig. 4g ). Furthermore, AEPs express minimal levels of Krt5 or Sox2 RNA and no detectable protein (Extended Data Figs 1f, 4e), further indicating that AEPs and Krt5 + cells derive from distinct lineages. In zone 4, Sftpc + and Krt5 + Sftpc + cells are very rare (Extended Data Fig. 4I ), which confirms previous reports 7 that the Krt5 + lineage cells do not efficiently regenerate Sftpc + cells except after forced Wnt activation 9 .
One month after influenza injury, AEPs and their progeny are present at homeostatic levels in zone 1. However, in zones 2 and 3 the number of AT2 cells expands significantly (Extended Data Fig. 4h) 11, 12 , with a large increase in the percentage of AT1 and AT2 cells arising from the AEP lineage ( Fig. 1j-l and Extended Data Figs 2d-i, 4j-l). This robust labelling is independent of the timing of tamoxifen injection before influenza infection (Extended Data Fig. 5g-h) . Notably, in zone 2 and zone 3 the AEP lineage shows a marked and specific increase in proliferation ( Fig. 1m and Extended Data Fig. 2k-o) . Three months after injury, within 300 microns of a persistent Krt5 + pod, a majority of AT2 cells and many AT1 cells in regenerated alveoli are derived from the AEP lineage ( Fig. 1o-q ). Immunohistochemistry and fluorescence-activated cell sorting (FACS) analysis after influenza injury demonstrate that AEPs self-renew to maintain the AEP lineage and generate a large number of new lineage-traced alveolar epithelial progeny ( Fig. 1n and Extended Data Figs 2j, 5a-e). Notably, few non-AEP AT2 cells acquire the AEP phenotype even in the setting of considerable lung injury ( Fig. 1n and Extended Data Fig. 5e ).
AEPs exhibit a distinct gene expression profile enriched in lung developmental genes ( Fig. 2a-d) , including the key genes Fgfr2, Nkx2-1, Id2, Etv4, Etv5 and Foxa1 (Extended Data Fig. 6 and Supplementary Table 1 ). Furthermore, analysis by assay for transposase-accessible chromatin using sequencing (ATAC-seq) (Extended Data Fig. 7 ) revealed a marked difference between AEPs and AT2 cells, with more than 40% of the genome containing differential open chromatin ( Fig. 2a ). Although many regions of common open chromatin are found near housekeeping genes, regions of AEP-enriched open chromatin are found near lung development genes (Extended Data Fig. 7c ). DNA binding-site motif analysis shows that AEP-enriched chromatin contains binding sites for AEP-enriched transcription factors of the Klf, Six, Sox, Nkx2 and Elf/Ets families (Extended Data Fig. 7d, e ), all of which are known to be regulators of progenitor cell behaviour [13] [14] [15] [16] [17] dynamically regulated in AEPs two weeks after influenza infection [18] [19] [20] [21] (Fig. 2b-d and Extended Data Fig. 6e-g) .
To isolate human AEPs, we identified cell surface markers that were enriched in mouse AEPs (Fig. 3a) . These studies identified the epithelial cancer stem cell membrane protein Tm4sf1 22,23 as a marker for mouse AEPs (Fig. 3b and Extended Data Fig. 8a-c) . Immunohistochemistry and FACS analysis demonstrates that Tm4sf1 marks approximately 20% of labelled mouse AT2 cells and more than 90% of mouse AEPs (Fig. 3c, d and Extended Data Fig. 8a ).
Using a combination of a human TM4SF1 antibody (Extended Data Fig. 8d ) and human-AT2-specific HTII-280 antibody 24 (Extended Data Fig. 8b , e-h), we were able to identify a distinct subset of HTII-280 + TM4SF1 + EPCAM + putative human AEPs in normal human lung. These human AEPs comprise approximately 29% of the human AT2 population ( Fig. 3e ) and express SFTPC, but not KRT5 or SOX2, mRNA ( Supplementary Table 2 ). Using clonal alveolar organoid assays 25 , both mouse AEPs and human AEPs form a greater number of, and larger, organoids that contain both AT1 and AT2 cells but no SOX2 + or KRT5 + cells (Extended Data Fig. 8i , j). AEPs also demonstrate increased responsiveness to Wnt modulation when compared to AT2 cells ( Fig. 3f -n and Extended Data Fig. 9 ). Notably, depletion of TM4SF1 + cells from the human AT2 population leads to a dramatic loss of organoid formation ( Fig. 3o-s ). Wnt inhibition promoted AT1 cell differentiation and Wnt activation promoted AT2 cell formation in both mouse and human organoids, but not in human AEP-depleted organoids ( Fig. 3o -r, u, v and Extended Data Fig. 9o, p) . These data suggest that TM4SF1 + HTII-280 + human AEPs are the functional equivalent of mouse AEPs.
RNA sequencing analysis (RNA-seq) demonstrated that a large proportion of human AEP-enriched genes (35.6%)-including key progenitor cell regulators-were evolutionarily conserved with mouse AEPs (Fig. 4a, b and Extended Data Fig. 10a, b ). In particular, mouse and human AEPs are both enriched for Wnt pathway targets, including AXIN2 and FGFR2; FGFR2 is the primary receptor for FGF7 and FGF10 [26] [27] [28] [29] [30] [31] [32] (Fig. 4c , Extended Data Fig. 10k and Supplementary Table 2 ). DNA binding motif analysis shows that TCF/LEF binding sites are enriched in open chromatin near conserved AEP genes, and β-catenin is bound to some of these genomic regions (Extended Data Fig. 10c-e ), supporting the idea that the Wnt-responsiveness of AEPs is evolutionarily conserved. Treatment of both mouse and human AEPs with FGF7 or FGF10 ligand resulted in substantial increases in colony size and colony-forming efficiency, whereas mouse AT2 and AEP-depleted human AT2 cells exhibited a diminished response ( Fig. 4d -w and Extended Data Fig. 10f -q).
Our data reveal that AEPs are a major lineage that contributes to functional alveolar epithelial regeneration by producing a large number of both AT2 and AT1 cells after injury. By contrast, Sox2-derived 
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Krt5 + cells migrate from the proximal airway after acute lung injury, preventing loss of the epithelial barrier [6] [7] [8] [9] . AEPs and Krt5 + cells are likely to act in concert: Krt5 + cells probably act rapidly to prevent immediate loss of epithelial barrier while AEPs simultaneously regenerate functional alveoli. AEPs respond robustly to both Wnt and Fgf signals: Wnt signalling is a key factor in modulating the AT2-to-AT1 transition 4 and Fgfr2 activation promotes AT2 cell proliferation (Extended Data Fig. 10j ). Importantly, the conservation and accessibility of both mouse and human AEPs provides an opportunity for mechanistic studies to shed light on human lung progenitor cell biology, and assist in the development of new treatments for acute and chronic lung diseases.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. Supplementary Information is available in the online version of the paper.
MethOdS Ethical compliance. All mouse studies were performed under guidance of the University of Pennsylvania Institutional Animal Care and Use Committee in accordance with institutional and regulatory guidelines. This study used cells derived from de-identified non-used lungs donated for organ transplantation via an established protocol (PROPEL, approved by University of Pennsylvania Institutional Review Board) with informed consent in accordance with institutional and NIH procedures. All patient information was removed before use. This use does not meet the current NIH definition of human subject research, but all institutional procedures required for human subject research were followed throughout the reported experiments. Mice and Cre recombinase induction. The generation and genotyping of the Axin2 creERT2-tdT mouse line generated in our laboratory has previously been described 4 . The Sftpc creERT2 mouse line was a gift of H. Chapman; their genotyping and generation have previously been described 34 . Hopx 3FlagGFP mice 35 were a gift of R. Jain and J. Epstein, and are available from Jackson Laboratories. The R26R eYFP mice are available from Jackson Laboratories. All mouse studies were performed under guidance of the University of Pennsylvania Institutional Animal Care and Use Committee. Mice were maintained on a mixed CD-1 and C57BL/6 background. For induction of all Cre recombinase models, tamoxifen (Sigma) was dissolved in 100% ethanol and diluted with corn oil (Sigma) to produce a 10% ethanol:tamoxifen:corn oil mixture at 20 mg/ml. Six-to-eight-week-old mice were injected intraperitoneally with 200 μ g per g body weight on between three and five conse cutive days to induce recombination. All lineage-tracing experiments represent a minimum of n = 6 mice in all groups to allow for effective statistical evaluation. qPCR experiments represent a minimum of n = 3 mice in all groups. Mouse experiments were performed on both male and female mice in all conditions, and mice were chosen at random from the cohort but not formally randomized. Blinding for experimental condition was not possible owing to the nature of the injury experiments. Influenza lung injury. PR8 H1N1 influenza was a gift of J. Wherry. Recombination for lineage tracing was performed using 3 daily tamoxifen injections, 7 or 28 days before viral infection. For infection, the virus was diluted in PBS and a dose of 0.3 LD 50 was administered via intranasal instillation. After infection, mice were weighed and monitored daily for 14-28 days, and mice that lost > 30% of their starting weight or were moribund were euthanized humanely. Post-influenza RNA was obtained at 14 days after infection, and lung regeneration was analysed from tissue collected from mice between 28 days and 3 months after infection. FACS data were generated from influenza-infected and uninfected mice using the same protocols, as described later. Regionalized lung injury was assessed via histology, and adjacent sections were used for all immunostaining and quantification. Histology. At the time of tissue collection, mice were euthanized by CO 2 inhalation. The chest cavity was exposed and the lungs cleared of blood by perfusion with cold PBS via the right ventricle. Lungs were inflated with 2% paraformaldehyde under constant pressure of 30 cm water, and allowed to fix overnight. Tissue was then dehydrated, paraffin embedded and sectioned. Haematoxylin and eosin staining was performed to examine morphology, and to score regions on the basis of the severity of injury. Immunohistochemistry was used to detect protein expression, using the following antibodies on paraffin sections: GFP (chicken, Aves, GFP-1020, 1:500), GFP (goat, Abcam, ab5450, 1:100), RFP (rabbit, Rockland, 600-901-379, 1:250), Scgb1a1 (goat, Santa Cruz, sc-9772, 1:20), Tubb4 (mouse, BioGenex, MU178-UC, 1:20), Sftpc (rabbit, Millipore, ABC99, 1:250), Sftpc (goat, Santa Cruz, sc-7750, 1:50), Pdpn (mouse, Hybridoma Bank, Clone 8.1.1, 1:50), Aqp5 (rabbit, Abcam, ab92320, 1:100), Ki67 (rabbit, Abcam, clone SP6, ab16667, 1:50) and anti-mouse Tm4sf1 (rabbit, LSBiosciences, B7077, 1:500). Alveolar epithelial cell number and lineage imaging and quantification. After immunostaining for alveolar epithelial lineages and proliferation, images were captured using a Nikon Eclipse Ni wide-field microscope or a Leica TCS SP8 confocal microscope. We captured images containing at least eight individual 1-μ m optical sections. Z-stacks were obtained from at least five random areas of each histological zone from a minimum of n = 5 mice. All images were processed with ImageJ software. Cell counts were performed using the Cell Counter plug-in for ImageJ. Cells were counted in at least three different areas of each histological injury zone for each mouse, to obtain a total count of > 1,000 cells counted for each condition. Only true confocal images were used for quantification. For image presentation, both confocal images and images obtained with automatic deconvolution algorithms in Nikon Elements software are presented, with source as noted. Lung alveolar epithelial cell isolation and FACS analysis. Mouse. Lungs from Axin2 creERT2-tdT mice were collected at 6-8 weeks of age and processed into a single-cell suspension using dispase, collagenase I and DNase, as previously described 36,37 . EPCAM + Axin2 + cells (tdTomato + ) were identified via FACS sorting, as previously described 37 . The total AT2 population (Sftpc + AT2 cells) was isolated from lungs of 6-8-week-old Sftpc creERT2 ;R26R eYFP mice 5 days after induction with 200 μ g per g body weight tamoxifen. eYFP + cells were then isolated via FACS sorting, as previously described 37 . For sorting and quantification, the following antibodies were used: Pdpn-eFluor660 (eBioscience, Clone 8.1.1, 1:100) EpCAM-APC (eBioscience, Clone G8.8, 1:200), EpCAM-eFluor488 (eBioscience, Clone G8.8, 1:200), CD31-PeCy7 (eBioscience, Clone 390, 1:200) and CD45-PeCy7 (eBioscience, Clone 30-F11, 1:200). Two anti-mouse Tm4sf1 antibodies were used to ensure specificity: sheep anti-mouse Tm4sf1 (R&D systems, AF7514, 1:10) and sheep IgG isotype control (R&D systems, 5-001-A, 1:10) with anti-sheep 488 secondary (Abcam, ab150177, 1:50) or rabbit anti-mouse Tm4sf1 (LS Biosciences, B7077, 1:25) and rabbit IgG isotype control (LS Biosciences, LS-C109221, 1:25) with donkey anti-rabbit 488 secondary (Life Technologies, A212016, 1:200).
Human. Samples of normal, de-identified human lungs were obtained from non-used lungs donated for organ transplantation via an established protocol (PROPEL, approved by University of Pennsylvania Institutional Review Board) with informed consent in accordance with institutional procedures. A 2 × 2 cm piece of distal lung tissue was obtained, pleura and large airways were carefully dissected away and tissue was processed into a single-cell suspension using the same combination of dispase, collagenase I and DNase that was used for mouse lungs. A Miltenyi gentleMACS dissociator was used for mincing and incubation for 35 min at 37 °C. Cells were washed, passed over 70-μ M and 40-μ M filters and red blood cells were lysed with ACK lysis buffer. After a single-cell suspension was obtained, cells were analysed by FACS or sorted using the MACS multisort kit, MACs LS columns and the following antibodies: EPCAM-PE (BD, mouse, Clone 1B7, 1:50), HT2-280 (mouse IgM, a gift of L. Dobbs, UCSF, 1:50), TM4SF1-APC (mouse, R&D Systems, Clone 877621, 1:100), Mouse IgG1-APC isotype control (R&D systems, 1C002A, 1:100), anti-APC microbeads (Miltenyi, 130-090-855, 1:20) and anti-mouse IgM microbeads (Miltenyi, 130-047-302, 1:20) . For the full protocol for digestion and sorting of human lung epithelial cells, and their propogation as alveolar organoids, see 'Data availability' . Ex vivo alveolar organoids. Clonal alveolar organoid assays were performed as previously described, with some modifications from the original protocol 4, 11, 25, 37 In brief, 5 × 10 3 epithelial cells (AT2 or AEP for mouse, HT2-280 + , HT2-280 + TM4SF1 + and HT2-280 + TM4SF1 − for human) were isolated as described earlier, and mixed with 5 × 10 4 lung fibroblasts (isolated from adult wild-type mice as previously described 37 for mouse; MRC5 cells (ATCC CCL-171, tested negative for mycobacterial contamination, at no greater than passage 10) for human). Cells were then suspended in a 1:1 mixture of SAGM medium (Lonza, with all additives except epinephrine) and growth factor-reduced, phenol-free Matrigel (Corning). Ninety microlitres of the cell-medium-Matrigel mixture was then aliquoted into individual 24-well cell culture inserts and allowed to solidify at 37 °C. SAGM was then placed into each well of the 24-well plate. The Rock inhibitor Y27632 (Sigma) was included in the medium for the first two days. After two days of culture, Y27632 was removed and ligand treatments of organoids were performed using the following reagents at the indicated concentrations: Wnt3a 200 ng/ml (R&D systems), Fgf7 50 ng/ml (R&D Systems), Fgf10 50 ng/ml (R&D Systems), XAV939 10 μ M (Sigma) and CHIR99021 1 μ M (Fisher). DMSO was used a control. The medium was changed every 48 h, and fresh ligands were included at each medium change. After 21 days of culture, organoids were fixed in 2% paraformaldehyde, embedded in Histogel (Richard-Allan), dehydrated, paraffin-embedded, and sectioned and immunostained as described earlier.
RNA-seq analysis. Cells were sorted using the protocols described earlier into Trizol LS (Life Technologies). For mouse, six individual mice were sorted and pooled into two individual pools for Axin2 + cells and three individual pools for Sftpc + cells. For human, cells from three individual patients were sorted separately and prepared for sequencing individually. RNA was then extracted using a combination of the Trizol protocol and MinElute RNA Cleanup Kit (Qiagen). RNA integrity was confirmed via Bionanalyzer evaluation and samples with RNA integrity numbers > 8.5 were chosen for library preparation. Library preparation was conducted using Illumina truSeq stranded mRNA kit, followed by the Nugen Ovation amplification kit. FASTQ files were assessed for quality control using the FastQC program. FASTQ files were aligned against the mouse reference genome (mm9) or human reference (hg19/hGRC37) genome using the STAR aligner 38 . Duplicate reads were flagged using the MarkDuplicates program from Picard tools. Per-gene read counts for Ensembl (v.67) gene annotations for the mouse samples or Ensembl (v.75) for the human samples were computed using the R package Rsubread, with duplicate reads removed. Gene counts represented as counts per million (CPM) were first nominalized using the trimmed mean of M-values method in the R package edgeR, and genes with a CPM < 1 in 25% of samples were removed and deemed to be low-expressed. These data were transformed using the VOOM function from the limma R package 39 . Differential gene expression was performed using a linear model with the limma package. Given the small sample size of the experiment, we employed the empirical Bayes procedure as implemented in limma to adjust the linear fit and calculate P values. P values were adjusted for Letter reSeArCH multiple comparisons using Benjamini-Hochberg procedure. For the human data, a paired analysis was employed using the patient as a blocking variable. Heat maps and principal component analysis plots were generated in R. Gene Ontology (GO) enrichment analysis was performed using the ToppGene Suite (http://toppgene. cchmc.org/) 40 . ATAC-seq analysis. Individual ATAC-seq libraries were generated from sorted Axin2 + and Sftpc + AT2 cells as described earlier, using previously published methods 41 . In brief, 5 × 10 4 cells were sorted into PBS, washed and lysed to obtain nuclei. Nuclei were exposed to Tn5 transposase (Illumina), and fractionated DNA was used for amplification and library preparation. Libraries were then purified and paired-end sequenced. After sequencing, FASTQ files were aligned against the mouse reference genome (mm9) using the STAR aligner 38 , with default parameters plus options to suppress the matching of spliced reads ('-outFilterMatchNmi-nOverLread 0.4-outFilterScoreMinOverLread 0.4'). Duplicate reads were flagged using the MarkDuplicates program from Picard tools and removed using samtools. MACS2 42 was used to call peaks with the following options '-nomodel-shift -100-extsize 200' . Differential ATAC-seq peaks were determined using the bdgdiff command from MACS2 and default options. Peaks were filtered to have a MACS2 log 10 likelihood ratio score > 10 and to be within − 50 kb and 10 kb of the transcription start site of Ensembl 67 protein-coding genes. ATAC-seq enrichment heat maps were created using deepTools2 43 . Motif analysis. The intersection of gene promoter regions (− 5 kb, 600 bp, Ensembl v.67) with identified ATAC-seq peaks was performed using bedtools. The FASTA file of genome sequence (mm9) of promoter ATAC-seq peaks was created using bedtools and scanned for TCF/LEF motifs using FIMO 44 . Motif enrichment analysis was performed using the findMotifsGenome.pl program in the HOMER software suite 45 , with the peak search size option set to 50 bp. Chromatin immunoprecipitation. Chromatin immunoprecipitation was performed using the High Sensitivity ChIP Kit (Abcam) with 3 μ g of anti-β -catenin (Santa Cruz sc-7963) or anti-IgG1 isotype control (Santa Cruz sc-3877). In brief, 1 × 10 5 Axin2 + or Sftpc + AT2 cells were sorted into SAGM (Lonza), whole chromatin was prepared, chromatin was cross-linked and sonicated using a Covaris sonicator to an optimal size of 300 bp, and chromatin was immunoprecipitated using the antibodies listed earlier, following the Abcam protocol. Library quality was confirmed using Bioanalyzer, and the enrichment of genomic DNA was assessed using qPCR to compare β -catenin immunoprecipitate to immunoprecipitate from an IgG control for each cell type. qPCR data represents n = 2 individual immunoprecipitation experiments, and was performed in triplicate. Statistical analysis. No statistical methods were used to predetermine sample size. Statistical analysis was performed in Prism for Mac, and R. A two-tailed Student's t-test was used for the comparison between two experimental groups. For experiments with more than two groups, an ANOVA was performed followed by planned contrasts; pairwise comparisons and P-value adjustments for multiple comparisons were performed using Dunnett's procedure. The generation of odds ratios for the distribution of ATAC regions near genes was evaluated using Fisher's exact test and contingency table analysis. Statistical data were considered significant when P < 0.05. Centre values of all plots represent means and error bars represent standard deviations, with the exception of error bars for odds ratios (which represent confidence intervals). Data availability. ATAC-seq and RNA-seq sequencing data generated during this study have been deposited in the Gene Expression Omnibus database with the primary accession GSE97055. All upregulated and downregulated genes identified during the RNA-seq experiments described in this paper are found in Supplementary 

Extended Data Figure 5 | Wnt signalling in the alveolar epithelium is largely stable after influenza infection, and AEP lineage labelling is not affected by tamoxifen perdurance. a, FACS gating strategy used for all post-influenza FACS experiments in Fig. 1, Extended Data Fig. 2 and b, c. SSC-A, side-scatter area, SSC-H, side-scatter height, FSC-H, forwardscatter height. b, c, FACS analysis demonstrates that Axin2 tdT intensity is mildly decreased in the epithelium at 7 and 14 days after influenza infection. d, In regions of milder lung injury, most lineage-labelled AT2 cells are eYFP + and tdTomato − , which suggests that these cells are the progeny of AEPs. e, In zone 3, we detect a mix of eYFP + tdTomato + AEPs (red arrowheads) and eYFP + tdTomato − AEP progeny (yellow arrowheads) among the AT2 cell population. f, Experimental design of lineage tracing experiment in g-i, with a longer incubation time after tamoxifen treatment than in the experiments that generated the data presented in a-e, and Fig. 1 and Extended Data Figs 4, 6. g, h, Confocal imaging demonstrating lineage labelling of AT2 cells with the AEP lineage mark 28 days after influenza-mediated injury. White arrows, unlabelled AT2 cells; yellow arrows, AEP-labelled cells. i, Quantification of lineage-labelled AT2 cells in multiple regions of lung injury. Representative seven-day lineage data is reproduced from Fig. 1 for comparison. Data shown represent n = 4 (a-c) or 5 (d-i) independent mice across two different experiments. Statistics are representative of all biological replicates. All data were analysed with ANOVA followed by preplanned pairwise comparisons and adjustment for multiple comparison testing, and are shown centred on mean with bars indicating standard deviation. * * P < 0.01. Scale bars, 50 μ m. 
Extended Data Figure 9 | Mouse AEPs generate more alveolar organoids compared to AT2 cells, and cells in these organoids are restricted from AT1 cell differentiation by Wnt signalling. a, Schematic of mouse alveolar organoid culture method. b-m, Sftpc + mouse AT2 cells (b-d, h-j) and mouse AEPs (e-g, k-m) were isolated from the indicated mouse lines and cultured in alveolar organoid assays. AT2 cells (b) and AEPs (e) both form alveolar organoids. AEPs generate more numerous and larger organoids than do AT2 cells. Activation of Wnt signalling using CHIR99021 does not increase the organoid-forming efficiency of either AT2 cells (c) or AEPs (f) but does increase the number of Sftpc + cells in treated organoids (i, l, o). Inhibition of Wnt signalling using XAV939 increases the number and size of alveolar organoids (d, g, n, q) , decreases the number of Sftpc + AT2 cells and increases the number of Aqp5 + AT1 cells (j, m, p). For tests of all parameters, AEPs exhibited a more marked response to Wnt modulation than did AT2 cells. Data shown represent n = 12 wells from n = 4 individual mice in each group, across 3 individual experiments. Quantitative counting shown for cell differentiation (o, p) represents counting of n > 400 organoids from n = 4 mice. All data were analysed with ANOVA followed by preplanned pairwise comparisons and adjustment for multiple comparison testing, and are shown centred on mean with bars indicating standard deviation. * P < 0.05, * * P < 0.01, * * * P < 0.001 and * * * * P < 0.0001. Statistics are representative of all biological replicates. Scale bars: 50 μ m. 
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Describe any data exclusions. No data were excluded
Replication
Describe whether the experimental findings were reliably reproduced.
There were no difficulties with reproduction of any of the reported findings. All experiments for this study are from multiple biological and technical replicates, with N and replication numbers reported in the legend of each Figure. 
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
For all animal experiments, experimental and control animals were chosen at random from among littermates with the appropriate genotype. All injury experiments were performed with uninjured littermates as controls. All animals in these studies were maintained on a similar mixed C57Bl/6 x CD1 genetic background. Both males and females were used in this study, and results are representative of data obtained from animals of both sexes.
For human studies, untreated or control samples from each individual were used as comparator for experimental manipulations on parallel samples. Larger numbers of technical replicates were used given the range of human genetic variation. No randomization was possible for these samples.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
The genotype of all animals was known to the investigators at the outset of the studies as all animals in each experiment and treatment group were littermates with the same genotype. Blinding to experimental condition was challenging as the reported influenza model caused obvious illness in animals and injury in examined tissues. Blinding to condition for quantitative counting was attempted but is not possible given the severity of injury and the morphological differences in injured tissues. For RNA-Seq: Fastq files were assessed for quality control using the FastQC program. Fastq files were aligned against the mouse reference genome (mm9) or human reference (hg19/hGRC37) genome using the STAR aligner 40. Duplicate reads were flag using the MarkDuplicates program from Picard tools. Per gene read counts for Ensembl (v67) gene annotations for the mouse samples or Ensembl (v75) for the human were computed using the R package Rsubread with duplicate reads removed. Gene counts represented as counts per million (CPM) were first nominalized using trimmed mean of M-values method in the R package edgeR and genes with 25% of samples with a CPM < 1 were removed and deemed low expressed. This data was transformed using the VOOM function from the limma R package. Differential gene expression was performed using a linear model with the limma package. Given the small sample size of the experiment, we employed the empirical Bayes procedure as implemented in limma to adjust the linear fit and calculate P values. P values were adjusted for multiple comparisons using Benjamini-Hochberg procedure. For the human data a paired analysis was employed using the patient as a blocking variable. Heatmaps and PCA plots were generated in R. Gene Ontology enrichment analysis was performed using the ToppGene Suite (http://toppgene.cchmc.org/).
For ATAC-Seq -Following sequencing, Fastq files were aligned against the mouse reference genome (mm9) using the STAR aligner 40, with default parameters plus options to suppress the matching of spliced reads ('--outFilterMatchNminOverLread 0.4 --outFilterScoreMinOverLread 0.4'). Duplicate reads were flagged using the MarkDuplicates program from Picard tools and removed using samtools. MACS2 was used to call peaks with the following options '--nomodel --shift -100 --extsize 200' 44. Differential ATAC-seq peaks were determined using the bdgdiff command from MACS2 and default options. Peaks were filtered to have a MACS2 log10 likelihood ratio score > 10 and within -50kb and +10kb of the transcription start site of Ensembl 67 protein coding genes. ATACseq enrichment heatmaps were created using deepTools2 .
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a for-profit company.
Axin2-CreERT2-tdTomato animals are available by request to Dr. Morrisey. . The Sftpc-CreERT2 line used in this study was developed by Dr. Harold Chapman, UCSF. These animals were a gift of Dr. Chapman and are available on request directly from Dr. Chapman.
All other animals and materials used in this manuscript are publicly available. Other mouse models used are available at the Jackson Laboratories.
Antibodies
Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species).
Extensive details of all antibodies used is available in the Materials and Methods
For Tm4sf1 antibodies: 1) Mouse -multiple Tm4sf1 antibodies were obtained and tested at multiple concentrations in IHC and FACS. Staining was confirmed as specific by FACS in comparison to an isotype antibody.
2) Human Tm4sf1-APC concentration was titrated by FACS, compared to isotype control antibody, and used at the optimal FACS concentration for cell sorting. Data is presented on the quality controls used for the human experiments.
Additional antibody information:
nature research | life sciences reporting summary c. Report whether the cell lines were tested for mycoplasma contamination.
All cells were tested negative for mycobacterial infection d. If any of the cell lines used are listed in the database of commonly misidentified cell lines maintained by ICLAC, provide a scientific rationale for their use.
No commonly misidentified lines were used
Animals and human research participants
Policy information about studies involving animals; when reporting animal research, follow the ARRIVE guidelines
Description of research animals
Provide details on animals and/or animal-derived materials used in the study.
All animal studies were performed under guidance of the University of Pennsylvania Institutional Animal Care and Use Committee. For all animal experiments, experimental and control animals were chosen at random from among littermates with the appropriate genotype. All injury experiments were performed with uninjured littermates as controls. All animals in these studies were maintained on a similar mixed C57Bl/6 x CD1 genetic background. Both males and females were used in this study, and results are representative of data obtained from animals of both sexes. Animals were housed in a barrier facility, with animals for influenza infection housed in a BSL-2 barrier facility.
For induction of all Cre recombinase models, tamoxifen (Sigma) was dissolved in 100% ethanol and diluted with corn oil to produce a 10% ethanol:tamoxifen:corn oil mixture at 20 mg/mL. 6-8 week old mice were injected intraperitoneally (IP) with 200mg/gm on 3-5 consecutive days to induce recombination. Number and timing of injection for all experiments is reported in the associated Figure. For influenza infection, we utilized PR8 influenza virus, which was a gift of Dr. John Wherry at the University of Pennsylvania. Virus was produced in their laboratory and titered based on LD50, and for experimental infection, virus was diluted in PBS and a dose of 0.3 LD50 was administered via intranasal instillation. Animals were monitored on a daily basis, with determination of weight and scoring of body condition on the BSC scale. In the event of rapid weight loss or dehydration, animals were provided with moistened chow and diet gel for support. Animals which lost >30% of weight or developed a BSC score of 1 (indicative of clinically relevant weight loss or dehydration) were sacrificed humanely prior to death. At the doses utilized in this study, less than 10% of animals met these IACUCapproved end-points. All other animals survived infection, and were analyzed at the planned regeneration end-point.
Policy information about studies involving human research participants
Description of human research participants
Describe the covariate-relevant population characteristics of the human research participants.
This study utilized cells derived from de-identified non-utilized lungs donated for organ transplantation via an established protocol (PROPEL, approved by University of Pennsylvania Institutional Review Board) with informed consent in accordance with institutional procedures. All patient information was removed prior to use. This use does not meet the current NIH definition of human subject research, but all institutional procedures required for human subject research were followed throughout the reported experiments.
